Xiaoming Lin, RN, MSc

Galderma Laboratories, L.P.
14600 Heritage Parkway
Fort Worth, TX
USA 76177
Papers:
Treatment of Moderate-to-Severe Glabellar Lines with Relabotulinumtoxina, a New Liquid Botulinum Toxin: Clinical Efficacy and Safety Results from the Ready-1 Phase III Trial